Prediction of Drug Binding Affinities by Comparative Binding Energy Analysis

Journal of Medicinal Chemistry

Volumn 38, Issue 14, 1995, Pages 2681-2691

  Ortiz, Angel R ^a,b   Pisabarro, M Teresa ^a,b   Gago, Federico ^b   Wade, Rebecca C ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPASE INHIBITOR;

ARTICLE; BINDING AFFINITY; DRUG BINDING; DRUG DESIGN; GENETIC ENGINEERING; HUMAN; INFLAMMATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

BINDING SITES; BINDING, COMPETITIVE; ELECTRICITY; HUMAN; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; PHOSPHOLIPASES A; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SYNOVIAL FLUID; THERMODYNAMICS;

EID: 0029000922     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00014a020     Document Type: Article

References (73)

1. Jolles, G., Wooldridge, K. R. H., Eds. Drug Design: Fact or Fantasy?; Academic Press: London, 1984.
2. Dean, P. M. Molecular Foundations of Drug-Receptor Interactions’, Cambridge University Press: Cambridge, 1987.
3. Navia, M. A.; Murcko, M. A. Use of structural information in drug design. Curr. Opin. Struct. Biol. 1992, 2, 202.
4. Hoi, W. J. Protein crystallography and computer graphics - toward rational drug design Angew. Chem., Int. Ed. Engl. 1986, 25, 767-778.
5. Goodford, P. J. Drug design by the method of receptor fit. J. Med. Chem. 1984, 27 (5), 556-564.
6. Kuntz, I. D. Structure-based strategies for drug design and discovery. Science 1992, 257, 1078-1082.
7. Greer, J.; Erickson, J. W.; Baldwin, J. J.; Varney, M. D. Application of the three-dimensional structures of protein target molecules in structure-based drug design. J. Med. Chem. 1994, 37 (8), 1035-1054.
8. Appelt, K.; Bacquet, R. J.; Barlett, C. A.; Booth, C. L. J.; Freer, S. T.; Fuhry, M. A. M.; Gehring, M. R.; Herrmann, S. M.; Howland, E. F.; Janson, C. A.; Jones, T. R.; Kan, C.-C.; Kathardekar, V.; Lewis, K. K.; Marzoni, G. P.; Matthews, D. A.; Mohr, C.; Moomaw, E. W.; Morse, C. A.; Oatley, S. J.; Ogden, R. C.; Reddy, M. R.; Reich, S. H.; Schoettlin, W. S.; Smith, W. W.; Varney, M. D.; Villafranca, J. E.; Ward, R. W.; Webber, S.; Webber, S. E.; Welsh, K. M.; White, J. Design of enzyme inhibitors using iterative protein crystallographic analysis. J. Med. Chem. 1991, 34 (7), 1925-1934.
9. Blaney, J. M.; Hansch, C. In Comprehensive Medicinal Chemistry. Vol. IV. Quantitative Drug Design’, Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: New York, 1990.
10. Reich, S. H.; Webber, S. E. Structure-Based drug Design (SBDD): Every structure tells a story. Perspect. Drug Discovery Des. 1993, 1, 371-390.
11. Beveridge, D. L.; DiCapua, F. M. Free energy via molecular simulation: Applications to chemical and biomolecular systems. Annu. Rev. Biophys. Biophys. Chem. 1989, 18, 431-492.
12. Straatsma, T. P.; McCammon, J. A. Computational alchemy. Annu. Rev. Phys. Chem. 1992, 43, 407-435.
13. van Gunsteren, W. F. In Computer Simulations of Biomolecular Systems: Theoretical and Experimental Applications’, van Gunsteren, W. F., Weiner, P. K., Eds.; ESCOM Science Publishers B. V.: Leiden 1989; pp 27-59.
14. Kollman, P. Free energy calculations: Applications to chemical and biochemical phenomena Chem. Rev. 1993, 93, 2395-2417.
15. Gupta, S. P. QSAR studies on enzyme inhibitors. Chem. Rev. 1987, 87, 1183-1253.
16. Kubinyi, H., Ed. 3D-QSAR in Drug Design. Theory, Methods and Applications’, ESCOM Science Publishers B. V.: Leiden, 1993.
17. Hansch, C.; Klein, T. E. Quantitative structure activity relationships and molecular graphics in evaluation of enzyme ligand interactions. Methods Enzymol. 1991, 202, 512-543.
18. Blaney, J. M.; Weiner, P. K.; Dearing, A.; Kollman, P. A.; Jorgensen, E. C.; Oatley, S. J.; Burridge, J. M.; Blake, C. C. F. Molecular mechanics simulation of protein-ligand interactions: Binding of Thyroid Hormone analogues to Prealbumin J. Am. Chem. Soc. 1982, 104, 6424-6434.
19. Menziani, M. C.; De Benedetti, P. G.; Gago, F.; Richards, W. G. The binding of benzene sulfonamides to carbonic anhydrase enzyme. A molecular mechanics study and quantitative structure-activity relationships. J. Med. Chem. 1989, 32, 951-956.
20. Garcia, M. L. Manuscript in preparation.
21. Cabre, F.; Carabaza, A.; Garcia, A. M.; Gomez, M.; Garcia, M. L.; Mauleon, D.; Carganico, G. Vlllth International Congress on Prostaglandins and Related Compounds, Montreal, 1992.
22. Carganico, G.; Mauleon, D.; Garcia, M. L. Spanish Patent Application, ES 9301180.
23. Pisabarro, M. T.; Ortiz, A. R.; Palomer, A.; Cabre, F.; Garcia, M. L.; Wade, R. C.; Gago, F.; Mauleon, D.; Carganico, G. Rational modification of human synovial fluid phospholipase A2 inhibitors. J. Med. Chem. 1994, 37, 337-341.
24. Dennis, E. A. Phospholipases. In The Enzymes; Boyer, P. B., Ed., Academic Press: New York, Vol. 16, pp 307-354.
25. Dennis, E. A. Regulation of eicosanoid production: role of phospholipase and inhibitors. Biotechnology 1987, 5, 1294-1300.
26. Mobilio, D.; Marshall, L. A. Recent advances in the design and evaluation of inhibitors ofPLA2. Annu. Rep. Med. Chem. 1989, 24, 157-166.
27. Pruzanski, W.; Vadas, P.; Stefanski, E.; Urowitz, M. B. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J. Rheumatol. 1988, 12, 211-216.
28. Hara, S.; Kudo, I.; Chang, H. W.; Matsuta, K.; Miyamoto, T.; Inoue, K. Purification and characterization of extracellular Phospholipase A2 from human synovial fluid in rheumatoid arthritis. J. Biochem. 1989, 105, 395-399.
29. Vadas, P.; Pruzanski, W.; Kim, J.; Fornasier, V. The proinflammatory effect of inter-articular injection of soluble human and venom Phospholipase A2. Am. J. Pathol. 1989, 134, 807-811.
30. Glaser, K. B.; Mobilio, D.; Chang, J. Y.; Senko, N. Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol. Sci. 1993, 14, 92-98.
31. Wery, J.-P.; Schevitz, R. W.; Clawson, D. K.; Bobbitt, J. L.; Dow, C. R.; Gamboa, G.; Goodson, T.; Hermann, R. B.; Kramer, R. M.; McClure, D. B.; Mihelich, E. D.; Putname, J. E.; Sharp, J. D.; Stark, D. H.; Teater, C.; Warrick, M. W.; Jones, N. D. Structure of Recombinant Human Rheumatoid Arthritic Synovial Fluid Phospholipase A2 at 2. 2 A Resolution. Nature 1991, 352, 79-82.
32. Scott, D. L.; White, S. P.; Browning, J. L.; Rosa, J. J.; Gelb, M. H.; Sigler, P. B. Structures of Free and Inhibited Human Secretory Phospholipase A2 from Inflammatory Exudate. Science 1991, 254, 1007-1010.
33. McQuarrie, D. A. Statistical Mechanics’, Harper & Row: New York, 1976.
34. Wold, S. Partial Least Squares Analysis. In 3D-QSAR in Drug Design: Theory, Methods and Applications’, Kubinyi, H., Ed.; ESCOM Science Publishers: Leiden, Holland, 1993.
35. Wold, S.; Wold, H.; Ruhe, A.; Dunn, W. J., III. The collinearity problem in linear regression. The Partial Least Squares (PLS) approach to generalized inverses. SIAM J. Sci. Stat. Comp. 1984, 5, 735-743.
36. Lindberg, W.; Persson, J. A.; Wold, S. Partial Least Squares method for spectrofluorometric analysis of mixtures of humic acid and ligninsulfonate. Anal. Chem. 1983, 55, 643-648.
37. Box, G. E. P.; Hunter, W. G.; Hunter, J. S. In Statistics for Experimenters’, Wiley, J. and Sons: New York, 1978; Chapter 12.
38. Thunnissen, M. M. G. M.; Eiso, A. B.; Kalk, K. H.; Drenth, J.; Dijkstra, B. W.; Kuipers, O. P.; Dijkman, R.; de Haas, G. H.; Verheij, H. M. X-ray structure of Phospholipase A2 complexed with a substrate-based inhibitor. Nature 1990, 347, 689-691.
39. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J. B.; Meyer, E. F., Jr.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The Protein Data Bank: A computer based archival file for macromolecular structures. J. Mol. Biol. 1977, 112, 535-542.
40. Maple, J. R.; Dinur, U.; Hagler, A. T. Derivation of Force Fields for Molecular Mechanics and Dynamics fron Ab initio Energy Surfaces. Proc. Nat. Acad. Sci. U. SA. 1988, 85, 5350.
41. Maple, J. R.; Thacher, T. S.; Dinur, U.; Hagler, A. T. Biosym Force Field Research Results in New Techniques for the Extraction of Inter- and Intramolecular Forces. Chem. Des. Autom. News 1990, 5 (9), 5-10.
42. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. CHARMM: A program for macromolecular energy minimization and dynamics calculations. J. Comput. Chem. 1983, 4, 187-217.
43. QUANTA 3. 3 Parameter Handbook 1992. Molecular Simulations Inc., 200 Fifth Avenue, Waltham, MA 02154.
44. Hopfinger, A. J.; Pearlstein, R. A. Molecular mechanics force- field parameterization procedures. J. Comput. Chem. 1984, 5, 486-499.
45. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. AMI: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
46. Stewart, J. J. P. MOPAC: A General Molecular Orbital Package, version 6.0; QCPE 455, Quantum Chemistry Program Exchange, Indiana, Bloomington, IN 47405.
47. Carlson, H. A.; Nguyen, T. B.; Orozco, M.; Jorgensen, W. L. Accuracy of free energies of hydration for organic molecules from 6-31G*-derived partial charges. J. Comput. Chem. 1993, 14 (10), 1240-1249.
48. Nicholas, J. B.; Vance, R.; Martin, E.; Burke, B. J.; Hopfinger, A. J. Molecular mechanics valence force field for sulfonamides derived by ab initio methods. J. Phys. Chem. 1991, 95, 9803-9811.
49. Besler, B. H.; Merz, K. M., Jr.; Kollman, P. A. Atomic charges derived from semiempirical methods. J. Comput. Chem. 1990, 11, 431-439.
50. McCammon, J. A.; Harvey, S. C. Dynamics of Proteins and Nucleic Acids; Cambridge University Press: Cambridge, UK, 1987.
51. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926.
52. Guenot, J. M.; Kollman, P. A. Molecular dynamics studies of a DNA-binding protein: 2. An evaluation of implicit and explicit solvent models for the molecular dynamics simulation of the Escherichia coli trp repressor. Protein Sci. 1992, 1, 1185-1205.
53. Guenot, J. M.; Kollman, P. A. Conformational and energetic effects of truncating nonbonded interactions in an aqueous protein dynamics simulation. J. Comput. Chem. 1993, 14, 295-311.
54. Baroni, M.; Constantino, G.; Cruciani, G.; Riganelli, D.; Valigi, R.; Clementi, S. Generating Optimal Linear PLS Estimations (GOLPE): An advanced chemometric tool for handling 3D-QSAR problems. Quant. Struct.-Act. Relat. 1993, 12, 9-20.
55. Mitchell, T. J. An algorithm for the construction of ‘D-optimal’ experimental designs. Technometrics 1974, 16, 203-210.
56. Press, W. H.; Flannepr, B. P.; Teukolsky, S. A.; Vetterling, W. T. In Numerical Recipes; Cambridge University Press: Cambridge, UK, 1989.
57. Wold, S. Validation of QSAR's Quant. Struct.-Act. Relat. 1991, 10, 191-193.
58. Scott, D. L.; White, S. P.; Otwinowski, Z.; Yuan, W.; Gelb, M. H.; Sigler, P. B. Interfacial catalysis: the mechanism of Phospholipase A2. Science 1990, 250, 1541-1546.
59. Clark, M.; Cramer, R. D., III The probability of chance correlation using Partial Least Squares (PLS). Quant. Struct.-Act. Relat. 1993, 12, 137-145.
60. Brooks, C. L., III; Karplus, M.; Pettitt, B. M. Proteins: A Theoretical Prespective on Structure, Dynamics and Thermodynamics; Advances in Chemical Physics; Wiley: New York, 1988; Vol. 71.
61. Elber, R.; Karplus, M. Multiple conformational states of proteins: a molecular dynamics analysis of myoglobin. Science 1987, 235, 318-321.
62. Wheeler, T. N.; Blanchard, S. G.; Andrews, R. C.; Fang, F.; Gray-Nunez, Y.; Harris, C. O.; Lambert, M. H.; Mehrotra, M. M.; Parks, D. J.; Ray, J. A.; Smalley, T. L. Substrate Specificity in Short-chain Phospholipid Analogs at the Active Site of Human Synovial Phospholipase A2. J. Med. Chem. 1995, 37, 4118-4129.
63. Sharp, K. A.; Honig, B. Electrostatic interactions in macromolecules: Theory and applications. Annu. Rev. Biophys. Biophys. Chem. 1990, 19, 301.
64. Seibel, G. L.; Kollman, P. A. Molecular Mechanics and the modeling of drug structures, in Comprehensive Medicinal Chemistry. Vol. 4: Quantitative Drug Design; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: New York, 1990; pp 125-138.
65. GRIN, GRID and GRAB (version 11), 1994. Molecular Discovery Ltd., West Way House, Elms Parade, Oxford OX2 9LL, England.
66. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important molecules. J. Med. Chem. 1985, 28, 849-857.
67. Boobbyer, D. N. A.; Goodford, P. J.; McWhinnie, P. M.; Wade, R. C. New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules pf known structure. J. Med. Chem. 1989, 32, 1083-1094.
68. Wade, R. C.; Clark, K. J.; Goodford, P. J. Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds. J. Med. Chem. 1993, 36, 140-147.
69. Wade, R. C.; Goodford, P. J. Further development of hydrogen-bond functions for use in determining energetically favorable binding sites on molecules of known structure. 2. Ligand probe groups with the ability to form more than two hydrogen bonds. J. Med. Chem. 1993, 36, 148-156.
70. Kuntz, I. D.; Blaney, J. M.; Oatley, S. J.; Langridge, R.; Ferrin, T. E. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol. 1982, 161, 269-288.
71. DesJarlais, R. L.; Sheridan, R. P.; Seibel, G. L.; Dixon, J. S.; Kuntz, I. D.; Venkataraghavan, R. Using shape complementary as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. J. Med. Chem. 1988, 31, 722-729.
72. Shoichet, B. K.; Stroud, R. M.; Santi, D. N.; Kuntz, I. D.; Perry, K. M. Structure-based discovery of inhibitors of thymidilate synthase. Science 1993, 259, 1445-1450.
73. Bohm, H. J. The computer program LUDI: A new simple method for the de-novo design of enzyme inhibitors. J. Comput.-Aided. Mol. Des. 1992, 6, 61-78.